BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Saleh MA, Mansoor E, Cooper GS. Case of familial hyperlipoproteinemia type III hypertriglyceridemia induced acute pancreatitis: Role for outpatient apheresis maintenance therapy. World J Gastroenterol 2017; 23(40): 7332-7336 [PMID: 29142480 DOI: 10.3748/wjg.v23.i40.7332]
URL: https://www.wjgnet.com/1007-9327/full/v23/i40/7332.htm
Number Citing Articles
1
Taylor H. Jacobs, Colton D. Wayne, Nitin Sajankila, Siddharth Narayanan. Pancreatitis Secondary to Dyslipidemia: An Understudied Condition. Lipidology 2024; 1(2) doi: 10.3390/lipidology1020009
2
Yahya Ayhan Acar, Gizem Gunay, Sedat Bilge, Onur Tezel. Concomitant hypertriglyceridemia-induced pancreatitis in pregnant monozygotic twin siblings. Gynecological Endocrinology 2020; 36(7) doi: 10.1080/09513590.2020.1737669
3
Yun Sun. Progress in diagnosis and treatment of hypertriglyceridemic acute pancreatitis. World Chinese Journal of Digestology 2020; 28(24) doi: 10.11569/wcjd.v28.i24.1223
4
Hiroaki Okazaki, Takanari Gotoda, Masatsune Ogura, Shun Ishibashi, Kyoko Inagaki, Hiroyuki Daida, Toshio Hayashi, Mika Hori, Daisaku Masuda, Kota Matsuki, Shinji Yokoyama, Mariko Harada-Shiba. Current Diagnosis and Management of Primary Chylomicronemia. Journal of Atherosclerosis and Thrombosis 2021; 28(9) doi: 10.5551/jat.RV17054
5
Deven Juneja, Omender Singh, Prashant Nasa, Ravi Jain. Plasmapheresis for Hypertriglyceridemia-induced Acute Pancreatitis: A Systematic Review and Meta-summary of Case Reports. Indian Journal of Critical Care Medicine 2025; 29(7) doi: 10.5005/jp-journals-10071-25010
6
A. V. Blokhina, A. I. Ershova, A. N. Meshkov, O. M. Drapkina. Familial dysbetalipoproteinemia: highly atherogenic and underdiagnosed disorder. Cardiovascular Therapy and Prevention 2021; 20(6) doi: 10.15829/1728-8800-2021-2893
7
Ramandeep Singh, Ranjodh Singh, Satinder Kakar, Jasmeet Kaur. Hypertriglyceridemia Induced Acute Pancreatitis: A Learn from New Cases. Sciences of Pharmacy 2023; 2(1) doi: 10.58920/sciphar02010001
8
Atorvastatin. Reactions Weekly 2018; 1683(1) doi: 10.1007/s40278-018-40050-y
9
M. V. Ezhov, V. V. Kukharchuk, T. V. Balakhonova, V. S. Gurevich, I. V. Sergienko, A. A. Sokolov, A. A. Semenkin, I. I. Shaposhnik, N. M. Akhmedzhanov, O. L. Barbarash, M. G. Bubnova, M. I. Voevoda, A. S. Galyavich, S. Ya. Eregin, G. A. Konovalov, V. A. Korneva, S. N. Pokrovsky, A. A. Raskurazhev, V. V. Skibitsky, M. M. Tanashyan, I. E. Chazova, A. E. Filippov, U. V. Chubykina, S. S. Yakushin. Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025). Eurasian heart journal 2025; (2) doi: 10.38109/2225-1685-2025-2-6-34
10
Anand Padmanabhan, Laura Connelly‐Smith, Nicole Aqui, Rasheed A. Balogun, Reinhard Klingel, Erin Meyer, Huy P. Pham, Jennifer Schneiderman, Volker Witt, Yanyun Wu, Nicole D. Zantek, Nancy M. Dunbar, Guest Editor: Joseph Schwartz. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue. Journal of Clinical Apheresis 2019; 34(3) doi: 10.1002/jca.21705
11
David M. Ng, John R. Burnett, Damon A. Bell, Robert A. Hegele, Amanda J. Hooper. Update on the diagnosis, treatment and management of rare genetic lipid disorders. Pathology 2019; 51(2) doi: 10.1016/j.pathol.2018.11.005